Type II abortion clinic definition

Type II abortion clinic means a facility, including a physician's office, but not including a general acute or specialty hospital, that:
Sample 1Sample 2Sample 3
Type II abortion clinic means a facility, including a physician's office, but not
Sample 1Sample 2Sample 3
Type II abortion clinic means a facility, including a physician's office, but not 3034 including a general acute or specialty hospital, that: 3035 (a) performs abortions, as defined in Section 76-7-301, after the first trimester of 3036 pregnancy; or 3037 (b) performs abortions, as defined in Section 76-7-301, during the first trimester of 3038 pregnancy and after the first trimester of pregnancy. 3039 Section 29. Section 26B-2-202 is amended to read: 3040 26B-2-202. Duties of department. 3041 (1) The department shall: 3042 (a) enforce rules established pursuant to this part; 3043 (b) authorize an agent of the department to conduct inspections of health care facilities 3044 pursuant to this part; 3045 (c) collect information authorized by the committee that may be necessary to ensure 3046 that adequate health care facilities are available to the public; 3047 (d) collect and credit fees for licenses as free revenue; 3048 (e) collect and credit fees for conducting plan reviews as dedicated credits; 3049 (f) (i) collect and credit fees for conducting [clearance] certification for direct patient 3050 access under Sections 26B-2-239 and 26B-2-240; and 3051 (ii) beginning July 1, 2012: 3052 (A) up to $105,000 of the fees collected under Subsection (1)(f)(i) are dedicated 3053 credits; and 3054 (B) the fees collected for background checks under Subsection 26B-2-240(6) and 3055 Subsection 26B-2-241(4) shall be transferred to the Department of Public Safety to reimburse 3056 the Department of Public Safety for its costs in conducting the federal background checks; 3057 (g) designate an executive secretary from within the department to assist the committee 3058 in carrying out its powers and responsibilities; 3059 (h) establish reasonable standards for criminal background checks by public and 3060 private entities; 3061 (i) recognize those public and private entities that meet the standards established 3062 pursuant to Subsection (1)(h); and 3063 (j) provide necessary administrative and staff support to the committee.
Sample 1

More Definitions of Type II abortion clinic

Type II abortion clinic means a facility, other than a general acute or specialty
Sample 1

Related to Type II abortion clinic

  • Designated chemical dependency specialist means a person

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase 2 Clinical Trial means a human clinical trial of a product that would satisfy the requirements of U.S. 21 C.F.R. Part 312.21(b), as amended, and is intended to explore a variety of doses, dose response, and duration of effect, and to generate evidence of clinical safety and effectiveness for a particular Indication or Indications in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase III Clinical Trial means a human clinical trial in any country, the results of which could be used to establish safety and efficacy of a Product as a basis for an NDA or would otherwise satisfy requirements of 21 CFR 312.21(c), or its foreign equivalent.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase IV Clinical Trial means a Clinical Trial conducted after Regulatory Approval of the applicable Product has been obtained from an appropriate Regulatory Authority as a condition to, or for the maintenance of, any Regulatory Approval, including a trial that would satisfy the requirements of 21 C.F.R. 312.85, as may be amended, or the foreign equivalent thereof.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Participating Prescription Drug Provider means an independent retail Pharmacy, chain of retail Pharmacies, mail-order Pharmacy or specialty drug Pharmacy which has entered into an agreement to provide pharmaceutical services to participants in the benefit program. A retail Participating Pharmacy may or may not be a select Participating Pharmacy as that term is used in the Vaccinations Obtained Through Participating Pharmacies section.

  • Pivotal Clinical Trial means a human clinical trial of a product on a sufficient number of subjects that, prior to commencement of the trial, satisfies both of the following ((a) and (b)):